Bleeding disorder of unknown cause: Results from Iranian study

• Published in: Transfusion and apheresis science Vol. 62; no. 5; p. 103730
• Main Authors: Zafarani, Alireza, Ghodratnia, Elnaz, Amirzargar, Mohammad Reza, Mahmoudi, Mohammad, Taghavi-Farahabadi, Mahsa, Tavangar, Fatemeh, Abdolkarimi, Babak, Tabibian, Shadi
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.10.2023
• Subjects: A Bleeding Disorder of Unknown Cause; Bleeding tendency; Mild bleeding disorders; A Bleeding Disorder of Unknown Cause; Mild bleeding disorders; Bleeding tendency
• ISSN: 1473-0502; 1878-1683
• DOI: 10.1016/j.transci.2023.103730

Definite diagnosis of patients with mild to moderate bleeding is challenging. Some studies reported that even more than 50% of their patients remained undiagnosed which is classified as a Bleeding disorder of unknown cause (BDUC). This study aims to document the clinical characteristics and proportion of patients with BDUC in the Iranian Comprehensive Hemophilia Care Center (ICHCC) one of the referral centers for diagnosis of congenital bleeding disorder in Iran. This study was conducted on 397 patients who were referred with a bleeding manifestation to ICHCC from 2019 to 2022. Demographic and laboratory data were documented for all patients. Bleeding questionnaires including ISTH-Bleeding Assessment tool (ISTH-BAT) and the Molecular and Clinical Markers for the Diagnosis and Management of Type 1 (MCMDM-1 (ISTH-BAT, MCMDM-1, and the Pictorial Bleeding Assessment Chart (PBLAC) were filled out for all patients. The data were analyzed by the statistical package for social science (SPSS version 22, SPSS, Chicago, Illinois, USA). BDUC was diagnosed in 200 patients and 197 patients reached the final diagnosis. Hemophilia, von Willebrand disease (VWD), factor (F) VII deficiency, and platelet functional disorders (PFDs) were confirmed in 54, 49, 34, and 15 of the patients, respectively. No significant difference was found in bleeding scores between patients with BDUC and those with confirmed disease. In contrast, after setting cut-off (ISTH-BAT for males ≥ 4 and females ≥ 6 and MCMDM-1 for males ≥ 3 and females ≥ 5) clinically significant difference was found. There was no association between having a positive consanguineous marriage and setting a diagnosis; however, significant associations were seen for having a positive family history of bleeding. Age (OR =0.977, 95% CI.965–0.989), gender (BDUC female, 151/200; final diagnosis female, 95/197) (OR=3.3, 95% CI 2.16–5.06), family history (OR = 3.19, 95% CI 1.99–5.11), and consanguineous marriage (OR=1.59, 95% CI 1.03–2.45) were considered as a risk factor for categorizing the patients with BDUC or final diagnosis. The findings are mainly in line with previous studies about BDUC patients. The large number of patients with BDUC underlines the incompleteness of available routine laboratory tests and shows the necessity of progress in the development of reliable diagnostic tools to identify underlying bleeding disorders.